DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer
NCT05728814
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
Dostarlimab
Sponsor
Grupo Español de Investigación en Cáncer de Ovario